Archives
-
GOB-38 β-Lactamase: Substrate Specificity and Resistance in
2026-06-09
This study characterizes the biochemical properties and substrate specificity of the novel GOB-38 metallo-β-lactamase from Elizabethkingia anophelis. By elucidating GOB-38’s broad hydrolytic activity and structural features, the research advances our understanding of antibiotic resistance mechanisms and potential interspecies gene transfer in clinical infections.
-
Energy Deficiency, ATG4B, and DNA Repair in AML Progression
2026-06-09
This study uncovers how energy deficiency in acute myeloid leukemia (AML) cells prompts the nuclear translocation of ATG4B, which disrupts PRMT1-mediated methylation of MRE11, impairing DNA repair and fostering leukemia progression. The findings illuminate a novel metabolic-genomic axis with therapeutic implications for targeting DNA repair vulnerabilities in AML.
-
Refining In Vitro Cancer Drug Evaluation: Insights from Schw
2026-06-08
Schwartz's dissertation critically redefines how in vitro drug responses are measured in cancer research, distinguishing proliferative arrest from cell death. The findings provide a framework for more precise preclinical drug evaluation and highlight methodological best practices for dissecting drug action mechanisms.
-
Lipo3K Transfection Reagent: High-Efficiency Workflow for Ch
2026-06-08
Lipo3K Transfection Reagent empowers high-efficiency DNA, siRNA, and mRNA delivery—even in notoriously difficult-to-transfect cells—while minimizing cytotoxicity. Its unique enhancer technology and streamlined workflow offer clear advantages for gene expression and RNA interference studies, outperforming many legacy lipid transfection reagents.
-
Cathepsin B Inhibitor CA-074: Technical Guidance and Protoco
2026-06-07
Cathepsin B inhibitor CA-074 provides nanomolar selectivity for dissecting the role of cathepsin B in cancer metastasis, neurotoxicity, and immune regulation. It is best suited for mechanistic studies where precise, low-cytotoxic inhibition of cathepsin B is needed, but is not intended for use in therapeutic or in vivo clinical applications.
-
Optimizing Immunoassays with TBST: Protocols & Troubleshooti
2026-06-06
TBST (Tris-Buffered Saline and Tween 20) is indispensable for high-fidelity immunoassays, offering reproducible blocking and washing that maximize signal-to-noise ratio while minimizing background. This guide translates bench-validated findings into actionable protocols, advanced applications, and troubleshooting insights for reliable antibody-based detection.
-
Rotigotine: Dopamine D2/D3 Receptor Agonist in PD Research
2026-06-05
Rotigotine stands out as a high-affinity dopamine D2/D3 receptor agonist, enabling reliable modeling of dopaminergic signaling and neuroprotection in Parkinson's disease workflows. Cutting-edge nanoparticle delivery and detailed protocol guidance unlock new research avenues, while troubleshooting tips ensure robust, reproducible results.
-
10 mM dNTP Mixture: Precision Workflows for DNA Synthesis
2026-06-05
Unlock reproducible, high-fidelity DNA amplification and sequencing with APExBIO's 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. This equimolar, pH-stabilized nucleotide solution streamlines complex molecular biology workflows from PCR to LNP-mediated delivery, while offering proven troubleshooting strategies for consistent results.
-
Distinguishing Growth Inhibition and Cell Death in Cancer Dr
2026-06-04
Schwartz's dissertation introduces a refined in vitro framework that differentiates drug-induced proliferative arrest from cell death, enhancing the precision of anti-cancer drug evaluation. This distinction offers researchers a more nuanced understanding of drug efficacy and informs optimal use of kinase inhibitors in cancer research.
-
FPH1 (BRD-6125) in Hepatocyte Expansion and Precision Therap
2026-06-04
Discover how FPH1 (BRD-6125) advances primary human hepatocyte culture and functional proliferation, with new insights into its synergy with optogenetic gene regulation. Explore the scientific depth, protocol nuances, and translational potential of this APExBIO molecule.
-
Lanabecestat (AZD3293): Deep Mechanistic Insights for Alzhei
2026-06-03
Explore the advanced mechanism and translational impact of Lanabecestat (AZD3293) in Alzheimer's disease research. This article delivers an in-depth analysis and protocol guidance, highlighting unique evidence from synaptic transmission studies and practical considerations for amyloid-beta pathway modulation.
-
In Silico Discovery of Peptide Inhibitors Targeting β-Lactam
2026-06-03
The referenced study introduces MDockPeP2_VS, a computational platform enabling automated, large-scale in silico screening of peptide inhibitors for protein targets such as TEM-1 β-lactamase. The work demonstrates the practicality of this approach by identifying a potent peptide inhibitor, advancing both peptide drug discovery and antibiotic resistance research.
-
Lyso-Tracker Red in Live-Cell Lysosome Imaging and Cancer Re
2026-06-02
Explore how Lyso-Tracker Red advances lysosome labeling in live cells, enabling precise analysis of lysosomal distribution and membrane dynamics. This article uniquely connects advanced fluorescence microscopy to emerging insights in cancer therapy and lysosomal membrane permeability.
-
Estradiol-ERα Regulation of T Cell Recovery After Hemorrhagi
2026-06-02
This study uncovers how 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by suppressing endoplasmic reticulum stress through ERα and GPR30, but not ERβ. The findings clarify receptor-specific mechanisms, offering new directions for research on immune dysfunction and estrogen receptor modulation post-trauma.
-
Brassinolide (SKU A3265): Data-Driven Solutions for Assay Re
2026-06-01
This article addresses persistent challenges in cell viability, proliferation, and cytotoxicity assays by showcasing how Brassinolide (SKU A3265) offers reproducible, literature-backed solutions for biomedical researchers. Drawing on validated protocols and comparative data, we guide users through best practices for experimental design, data interpretation, and product selection, ensuring robust results across cancer and metabolic disease models.